Beiqin Yu

机构：Ruijin Hospital, Shanghai Institute of Hematology · ORCID：0000-0003-1043-0445

发表论文 98 篇 · 总被引 3527 次 · h-index 32

代表论文

• Super‐enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5‐FU Resistance in Gastric Cancer (2024 · Advanced Science · 被引 21)
• SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer (2024 · EBioMedicine · 被引 12)
• Deciphering of intra‐tumoural heterogeneity and the interplay between metastasis‐associated meta‐program and myofibroblasts in gastric cancer (2025 · Clinical and Translational Medicine · 被引 11)
• LncRNA BASP1-AS1 drives PCBP2 K115 lactylation to suppress ferroptosis and confer oxaliplatin resistance in gastric cancer (2025 · Free Radical Biology and Medicine · 被引 9)
• Identification and validation of platinum resistance signature in gastric cancer (2025 · Cancer Cell International · 被引 2)
• Targeting CBP revers chemoresistance to 5‐FU of CDX2/REG4 double‐positive gastric cancer (2024 · Clinical and Translational Medicine · 被引 1)